Cited by 336Cardiomyopathy and Myosin StudiesCardiovascular Effects of ExerciseViral Infections and Immunology Research

The DOI matches its Crossref record; 318 of the 318 references it cites were found in a registry or an index.

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Writing Committee Members, Ommen, Steve R., Mital, Seema, Burke, Michael A., Day, Sharlene M., Deswal, Anita, Elliott, Perry, Evanovich, Lauren L., Hung, Judy, Joglar, José A., Kantor, Paul, Kimmelstiel, Carey, Kittleson, Michelle, Link, Mark S., Maron, Martin S., Martinez, Matthew W., Miyake, Christina Y., Schaff, Hartzell V., Semsarian, Christopher, Sorajja, Paul·2020·Circulation

DOI 10.1161/cir.0000000000000938

Open this paper in CoChat — free account

Abstract

Aim: This executive summary of the hypertrophic cardiomyopathy clinical practice guideline provides recommendations and algorithms for clinicians to diagnose and manage hypertrophic cardiomyopathy in adult and pediatric patients as well as supporting documentation to encourage their use. Methods: A comprehensive literature search was conducted from January 1, 2010, to April 30, 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Collaboration, Agency for Healthcare Research and Quality reports, and other relevant databases. Structure: Many recommendations from the earlier hypertrophic cardiomyopathy guidelines have been updated with new evidence or a better understanding of earlier evidence. This summary operationalizes the recommendations from the full guideline and presents a combination of diagnostic work-up, genetic and family screening, risk stratification approaches, lifestyle modifications, surgical and catheter interventions, and medications that constitute components of guideline directed medical therapy. For both guideline-directed medical therapy and other recommended drug treatment regimens, the reader is advised to follow dosing, contraindications and drug-drug interactions based on product insert materials.

Integrity signals

Registry

Crossref · 10.1161/cir.0000000000000938

Cites

318 of 318 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000678 · Cited by 4,536
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu284 · Cited by 4,332
Self-citation
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Fleisher, L. A., Jneid, H. M., Mack, M. J., McLeod, C. J., O’Gara, P. T., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.011 · Cited by 3,380
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Fleisher, L. A., Jneid, H. M., Mack, M. J., McLeod, C. J., O’Gara, P. T., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000503 · Cited by 2,544
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy
Regitz-Zagrosek, V., Roos-Hesselink, J. W., Bauersachs, J., Blomström-Lundqvist, C., Cífková, R., De Bonis, M., Iung, B., Johnson, M. R., Kintscher, U., Kranke, P., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy340 · Cited by 2,292
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M. L., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T. B., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8776 · Cited by 2,234
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e2bd · Cited by 2,116
Self-citation

Show all 317 references

Research works printed but not linked: 1

10.1161/jaha.116.005152 · DOI

Sorted by citations

Global burden of atrial fibrillation/atrial flutter and its attributable risk factors from 1990 to 2021
Cheng, S., He, J., Han, Y., Han, S., Li, P., Liao, H., & Guo, J. (2024) · EP Europace · doi:10.1093/europace/euae195 · Cited by 285
Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy
Zhou, M., Ta, S., Hahn, R. T., Hsi, D. H., Leon, M. B., Hu, R., Zhang, J., Zuo, L., Li, J., Wang, J., et al. (2022) · JAMA Cardiology · doi:10.1001/jamacardio.2022.0259 · Cited by 107
Diagnostic and prognostic role of late gadolinium enhancement in cardiomyopathies
Aquaro, G. D., Gori, C. D., Faggioni, L., Parisella, M. L., Cioni, D., Lencioni, R. A., & Neri, E. (2023) · European Heart Journal Supplements · doi:10.1093/eurheartjsupp/suad015 · Cited by 106
Arrhythmias as Presentation of Genetic Cardiomyopathy
Laws, J. L., Lancaster, M. C., Shoemaker, M. B., Stevenson, W. G., Hung, R. R., Wells, Q. S., Brinkley, D. M., Hughes, S. G., Anderson, K. C., Roden, D. M., et al. (2022) · Circulation Research · doi:10.1161/circresaha.122.319835 · Cited by 92
Friedreich Ataxia: Multidisciplinary Clinical Care
Lynch, D. R., Schadt, K. A., Kichula, E. A., McCormack, S. E., & Lin, K. Y. (2021) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s292945 · Cited by 73
Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy
Nauffal, V., Marstrand, P., Han, L., Parikh, V. N., Helms, A. S., Ingles, J., Jacoby, D. L., Lakdawala, N. K., Kapur, S., Michels, M., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab598 · Cited by 69
Self-citation
External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy
Norrish, G., Chen, Q., Field, E., Cervi, E., Khraiche, D., Klaassen, S., Ojala, T. H., Sinagra, G., Yamazawa, H., Marrone, C., et al. (2021) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwab181 · Cited by 69
Self-citation
Ramadan fasting: recommendations for patients with cardiovascular disease
Akhtar, A. M., Ghouri, N., Chahal, C. A. A., Patel, R. S., Ricci, F., Sattar, N. A., Waqar, S., & Khanji, M. Y. (2021) · Heart · doi:10.1136/heartjnl-2021-319273 · Cited by 66
Atrial Fibrillation in Patients With Cardiomyopathy: Prevalence and Clinical Outcomes From Real‐World Data
Buckley, B. J. R., Harrison, S. L., Gupta, D., Fazio‐Eynullayeva, E., Underhill, P., & Lip, G. Y. H. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.021970 · Cited by 64
Left Ventricular Hypertrophy: Etiology-Based Therapeutic Options
Sayın, B. Y., & Oto, A. (2022) · Cardiology and Therapy · doi:10.1007/s40119-022-00260-y · Cited by 60
Metabolic characterization of hypertrophic cardiomyopathy in human heart
Wang, W., Wang, J., Yao, K., Wang, S., Nie, M., Zhao, Y., Wang, B., Pang, H., Xu, J., Wu, G., et al. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00057-1 · Cited by 58
Genetic Testing in Patients with Hypertrophic Cardiomyopathy
Bonaventura, J., Polaková, E., Vejtasová, V., & Veselka, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910401 · Cited by 55
Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic Cardiomyopathy
Norrish, G., Cleary, A., Field, E., Cervi, E., Boleti, O., Ziółkowska, L., Olivotto, I., Khraiche, D., Limongelli, G., Anastasakis, A., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.03.347 · Cited by 52
Transcatheter Myotomy to Relieve Left Ventricular Outflow Tract Obstruction: The Septal Scoring Along the Midline Endocardium Procedure in Animals
Khan, J. M., Bruce, C. G., Greenbaum, A. B., Babaliaros, V. C., Jaimes, A. E., Schenke, W. H., Ramasawmy, R., Seemann, F., Herzka, D. A., Rogers, T., et al. (2022) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.121.011686 · Cited by 51
Thin filament cardiomyopathies: A review of genetics, disease mechanisms, and emerging therapeutics
Keyt, L. K., Duran, J. M., Bui, Q. M., Chen, C., Miyamoto, M. I., Enciso, J. S., Tardiff, J. C., & ADLER, E. D. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.972301 · Cited by 50
Hospital Procedural Volume and Clinical Outcomes Following Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy
Altibi, A. M. A., Ghanem, F. H., Zhao, Y., Elman, M., Cigarroa, J. E., Nazer, B., Song, H. K., & Masri, A. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.028693 · Cited by 50
Cardiac Myosin Inhibitors as a Novel Treatment Option for Obstructive Hypertrophic Cardiomyopathy: Addressing the Core of the Matter
Masri, A., & Olivotto, I. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.024656 · Cited by 48
Randomized Controlled Trial of Moderate‐ and High‐Intensity Exercise Training in Patients With Hypertrophic Cardiomyopathy: Effects on Fitness and Cardiovascular Response to Exercise
MacNamara, J. P., Dias, K. A., Hearon, C. M., Ivey, E., Delgado, V. A., Saland, S., Samels, M. R., Hieda, M., Turer, A. T., Link, M. S., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.031399 · Cited by 46
Self-citation
Apical hypertrophic cardiomyopathy: pathophysiology, diagnosis and management
Li, J., Fang, J., Liu, Y., & Wei, X. (2023) · Clinical Research in Cardiology · doi:10.1007/s00392-023-02328-8 · Cited by 44
Diagnosis and Management of Patients with Left Ventricular Hypertrophy: Role of Multimodality Cardiac Imaging. A Scientific Statement of the Heart Failure Association of the European Society of Cardiology
Moura, B., Aimo, A., Al‐Mohammad, A., Keramida, K., Gal, T. B., Dorbala, S., Todiere, G., Cameli, M., Barison, A., Bayés‐Genís, A., et al. (2023) · European Journal of Heart Failure · doi:10.1002/ejhf.2997 · Cited by 44
Modeling hypertrophic cardiomyopathy with human cardiomyocytes derived from induced pluripotent stem cells
Li, J., Feng, X., & Wei, X. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02905-0 · Cited by 42
Prevalence, incidence and mortality of hypertrophic cardiomyopathy based on a population cohort of 21.9 million in China
Bai, Y., Zheng, J.-P., Lu, F., Zhang, X.-L., Sun, C.-P., Guo, W.-H., Zou, Y.-X., Lip, G. Y. H., & Shi, X.-B. (2022) · Scientific Reports · doi:10.1038/s41598-022-20042-9 · Cited by 41
Implantable defibrillators in primary prevention of genetic arrhythmias. A shocking choice?
Corrado, D., Link, M. S., & Schwartz, P. J. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac298 · Cited by 41
Self-citation
Molecular Diagnosis of Hypertrophic Cardiomyopathy (HCM): In the Heart of Cardiac Disease
Melas, M., Beltsios, E. T., Adamou, A., Koumarelas, K. E., & McBride, K. L. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm12010225 · Cited by 37
Young athlete’s growing heart: sex differences in cardiac adaptation to exercise training during adolescence
Forså, M. I., Bjerring, A. W., Haugaa, K. H., Smedsrud, M. K., Sarvari, S. I., Landgraff, H. W., Hallén, J., & Edvardsen, T. (2023) · Open Heart · doi:10.1136/openhrt-2022-002155 · Cited by 36
Is There a Sex Difference in the Prognosis of Hypertrophic Cardiomyopathy? A Systematic Review and Meta‐Analysis
Zhao, H., Tan, Z., Liu, M., Yu, P., Ma, J., Li, X., Wang, J., Zhao, Y., Zhu, W., & Liu, X. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.026270 · Cited by 35
Eighteen‐Month Real‐World Experience Using Mavacamten for Treatment of Obstructive Hypertrophic Cardiomyopathy in a Racially Diverse Population
Ramonfaur, D., Gasperetti, A., Blake, V., Rivers, B. J., Kassamali, A. A., Kasper, E. K., Barouch, L. A., Wu, K. C., Madrazo, J., & Carrick, R. T. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.034069 · Cited by 34
Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Rationale for Clinically Guided Dose Titration to Optimize Individual Response
OWENS, A. T., Desai, M. Y., Wheeler, M. T., Rodonski, A., Merali, S. J., Sehnert, A. J., & Saberi, S. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.033767 · Cited by 31
Emerging Medical Treatment for Hypertrophic Cardiomyopathy
Argirò, A., Zampieri, M., Berteotti, M., Marchi, A. G., Tassetti, L., Zocchi, C., Iannone, L., Bacchi, B., Cappelli, F., Stefàno, P., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10050951 · Cited by 31
Role of Genetics in Diagnosis and Management of Hypertrophic Cardiomyopathy: A Glimpse into the Future
Abbas, M. T., Ali, N. B., Farina, J., Mahmoud, A., Pereyra, M., Scalia, I. G., Kamel, M., Barry, T., Lester, S. J., Cannan, C. R., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12030682 · Cited by 30
Advancing Sports Cardiology: Integrating Artificial Intelligence with Wearable Devices for Cardiovascular Health Management
Zheng, X. H., Liu, Z., Liu, J., Hu, C., Du, Y., Li, J., Pan, Z., & Ding, K. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c22895 · Cited by 30
Real-World Candidacy to Mavacamten in a Contemporary Hypertrophic Obstructive Cardiomyopathy Population
Bertero, E., Chiti, C., Schiavo, M. A., Tini, G., Costa, P., Todiere, G., Mabritto, B. M. T., Dei, L., Giannattasio, A., Mariani, D., et al. (2023) · European Journal of Heart Failure · doi:10.1002/ejhf.3120 · Cited by 30
Aficamten and Cardiopulmonary Exercise Test Performance
Lee, M. M. Y., Masri, A., Nassif, M. E., Villa, R. B., Abraham, T. P., Claggett, B. L., COATS, C. J., Gimeno, J. R., Kulac, I. J., Landsteiner, I., et al. (2024) · JAMA Cardiology · doi:10.1001/jamacardio.2024.2781 · Cited by 29
Self-citation
Pediatric Hypertrophic Cardiomyopathy: Exploring the Genotype‐Phenotype Association
Nguyen, M. B., Mital, S. R., Mertens, L., Jeewa, A., Friedberg, M. K., Aguet, J., Adler, A., Lam, C. Z., Dragulescu, A., Rakowski, H., et al. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.024220 · Cited by 29
Self-citation
Familial Hypertrophic Cardiomyopathy: Diagnosis and Management
Litt, M. J., Ali, A., & Reza, N. (2023) · Vascular Health and Risk Management · doi:10.2147/vhrm.s365001 · Cited by 29
Machine learning algorithms to automate differentiating cardiac amyloidosis from hypertrophic cardiomyopathy
Wu, Z.-W., Zheng, J.-L., Kuang, L., & Yan, H. (2022) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-022-02738-1 · Cited by 30
Multi-Omics Profiling of Hypertrophic Cardiomyopathy Reveals Altered Mechanisms in Mitochondrial Dynamics and Excitation–Contraction Coupling
Moore, J., Ewoldt, J. K., Venturini, G., Pereira, A. C., Padilha, K., Lawton, M. L., Lin, W., Goel, R. K., Luptak, I., Perissi, V., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054724 · Cited by 29
Echocardiography-based machine learning algorithm for distinguishing ischemic cardiomyopathy from dilated cardiomyopathy
Zhou, M. L., Deng, Y., Liu, Y., Su, X., & Zeng, X. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03520-4 · Cited by 28
Machine learning techniques for arrhythmic risk stratification: a review of the literature
Chung, C. T., Bazoukis, G., Lee, S., Liu, Y., Liu, T., Letsas, Κ. P., Armoundas, A. A., & Tse, G. (2022) · International Journal of Arrhythmia · doi:10.1186/s42444-022-00062-2 · Cited by 26
Disease Expression and Outcomes in Black and White Adults With Hypertrophic Cardiomyopathy
Arabadjian, M. E., Yu, G., Sherrid, M. V., & Dickson, V. V. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.019978 · Cited by 26
Prediction of Genotype Positivity in Patients With Hypertrophic Cardiomyopathy Using Machine Learning
Liang, L. W., Fifer, M. A., Hasegawa, K., Maurer, M. S., Reilly, M. P., & Shimada, Y. J. (2021) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.120.003259 · Cited by 25
Real-World Use and Predictors of Response to Disopyramide in Patients with Obstructive Hypertrophic Cardiomyopathy
Maurizi, N., Chiriatti, C., Fumagalli, C., Targetti, M., Passantino, S., Antiochos, P., Skalidis, I., Chiti, C., Biagioni, G., Tomberli, A., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12072725 · Cited by 25
Model for classification of heart failure severity in patients with hypertrophic cardiomyopathy using a deep neural network algorithm with a 12-lead electrocardiogram
Togo, S., Sugiura, Y., Suzuki, S., Ohno, K., Akita, K., Suwa, K., Shibata, S., Kimura, M., & Maekawa, Y. (2023) · Open Heart · doi:10.1136/openhrt-2023-002414 · Cited by 24
Evaluation of the 2021 ESC Recommendations for Family Screening in Hereditary Transthyretin Cardiac Amyloidosis
Muller, S. A., Aventín, B. P., Biagioni, G., Tini, G., Saturi, G., Kronberger, C., Achten, A., Dobner, S., Rijdt, W. P. T., Gasperetti, A., et al. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3339 · Cited by 24
Relationship Between Maximal Left Ventricular Wall Thickness and Sudden Cardiac Death in Childhood Onset Hypertrophic Cardiomyopathy
Norrish, G., Ding, T., Field, E., Cervi, E., Ziółkowska, L., Olivotto, I., Khraiche, D., Limongelli, G., Anastasakis, A., Weintraub, R. G., et al. (2022) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.121.010075 · Cited by 24
Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A Contemporary Perspective
Gragnano, F., Pelliccia, F., Guarnaccia, N., Niccoli, G., Rosa, S. D., Piccolo, R., Moscarella, E., Fabris, E., Montone, R. A., Cesaro, A., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12082810 · Cited by 24
Identification of high-risk imaging features in hypertrophic cardiomyopathy using electrocardiography: A deep-learning approach
Carrick, R. T., Ahamed, H., Sung, E., Maron, M. S., Madias, C. A., Avula, V. R., Studley, R., Chen, B., Bokhari, N. A., Quintana, E., et al. (2024) · Heart Rhythm · doi:10.1016/j.hrthm.2024.01.031 · Cited by 24
Self-citation
Childhood Hypertrophic Cardiomyopathy: A Disease of the Cardiac Sarcomere
Norrish, G., Field, E., & Kaski, J. P. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.708679 · Cited by 23
The Genetic Architecture of Hypertrophic Cardiomyopathy in Hungary: Analysis of 242 Patients with a Panel of 98 Genes
Sepp, R., Haţegan, L., Csányi, B., Borbás, J., Tringer, A., Pálinkás, E. D., Nagy, V., Takács, H., Latinovics, D., Nyolczas, N., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12051132 · Cited by 23
Tandem deep learning and logistic regression models to optimize hypertrophic cardiomyopathy detection in routine clinical practice
Maanja, M., Noseworthy, P. A., Geske, J. B., Ackerman, M. J., Arruda-Olson, A. M., Ommen, S. R., Attia, Z. I., Friedman, P. A., & Siontis, K. C. (2022) · Cardiovascular Digital Health Journal · doi:10.1016/j.cvdhj.2022.10.002 · Cited by 22
Self-citation
Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy and the impact of mavacamten
Mathai, S., & Williams, L. K. (2022) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223221136074 · Cited by 22
Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic Cardiomyopathy During Childhood: Insights From the SHaRe Registry
Alaiwi, S. A., Roston, T. M., Marstrand, P., Claggett, B. L., Parikh, V. N., Helms, A. S., Ingles, J., Lampert, R. J., Lakdawala, N. K., Michels, M., et al. (2023) · Circulation · doi:10.1161/circulationaha.122.062517 · Cited by 22
Self-citation
Predictive value of left atrial strain analysis in adverse clinical events in patients with hypertrophic cardiomyopathy: a CMR study
Tian, D., Zhang, J., He, Y., Xiong, Z., Zhao, M., Hu, S., Song, Q., & Li, Z. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03069-2 · Cited by 21
Deficiency of Transcription Factor Sp1 Contributes to Hypertrophic Cardiomyopathy
Zhang, F., Zhou, H., Xue, J., Zhang, Y., Zhou, L., Leng, J., Fang, G., Liu, Y., Wang, Y., Liu, H., et al. (2024) · Circulation Research · doi:10.1161/circresaha.123.323272 · Cited by 21
Aficamten: A Breakthrough Therapy for Symptomatic Obstructive Hypertrophic Cardiomyopathy
Sebastian, S. A., Padda, I., Lehr, E. J., & Johal, G. (2023) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-023-00599-0 · Cited by 20
Effect of Mavacamten in Women Compared With Men With Obstructive Hypertrophic Cardiomyopathy: Insights From EXPLORER-HCM
Cresci, S., Bach, R. G., Saberi, S., OWENS, A. T., Spertus, J. A., Hegde, S. M., Lakdawala, N. K., Nilles, E. K., WOJDYLA, D. M., Sehnert, A. J., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.065600 · Cited by 20
Disparities in heart and lung transplantation
Tsuang, W. M., Khedraki, R., & Hsich, E. (2021) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000916 · Cited by 20
Deep Neural Network for Cardiac Magnetic Resonance Image Segmentation
Chen, D. J., Bhopalwala, H. M., Dewaswala, N., Arunachalam, S. P., Enayati, M., Farahani, N. Z., Pasupathy, K. S., Lokineni, S., Bos, J. M., Noseworthy, P. A., et al. (2022) · Journal of Imaging · doi:10.3390/jimaging8050149 · Cited by 19
Remodelling of potassium currents underlies arrhythmic action potential prolongation under beta-adrenergic stimulation in hypertrophic cardiomyopathy
Doste, R., Coppini, R., & Bueno‐Orovio, A. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.08.361 · Cited by 19
Artificial intelligence in the pediatric echocardiography laboratory: Automation, physiology, and outcomes
Nguyen, M. B., Villemain, O., Friedberg, M. K., Løvstakken, L., Rusin, C. G., & Mertens, L. (2022) · Frontiers in Radiology · doi:10.3389/fradi.2022.881777 · Cited by 19
Role of Biomarkers of Myocardial Injury to Predict Adverse Outcomes in Hypertrophic Cardiomyopathy
Zhang, Y., Liu, M., Zhang, C., Zou, Y., Kang, L., & Song, L. (2024) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.123.010243 · Cited by 19
Mavacamten for hypertrophic cardiomyopathy: effectiveness and value
Beinfeld, M. T., Wasfy, J. H., Walton, S. M., Sarker, J., Nhan, E., Rind, D. M., & Pearson, S. D. (2022) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2022.28.3.369 · Cited by 19
Performance of heart rate adjusted heart rate variability for risk stratification of sudden cardiac death
Yan, S.-P., Song, X., Wei, L. B., Gong, Y., Hu, H.-Y., & Li, Y. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03184-0 · Cited by 18
Developing a genetic testing panel for evaluation of morbidities in kidney transplant recipients
Ma, B. M., Elefant, N., Tedesco, M., Bogyo, K., Vena, N., Murthy, S. B. K., Bheda, S., Yang, S. Y.-R., Tomar, N., Zhang, J. Y., et al. (2024) · Kidney International · doi:10.1016/j.kint.2024.02.021 · Cited by 18
The clinical utility of pediatric cardiomyopathy genetic testing: From diagnosis to a precision medicine-based approach to care
Parker, L. E., & Landstrom, A. P. (2021) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2021.101413 · Cited by 18
Current and Potential Applications of Wearables in Sports Cardiology
Rao, P., Seshadri, D. R., & Hsu, J. J. (2021) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-021-00942-1 · Cited by 18
Augmented risk of ischemic stroke in hypertrophic cardiomyopathy patients without documented atrial fibrillation
Choi, Y., Kim, B., Rhee, T., Lee, H., Lee, H., Park, J., Lee, S., Han, K., Kim, Y.-J., & Kim, H. (2022) · Scientific Reports · doi:10.1038/s41598-022-19895-x · Cited by 18
Founder mutation in myosin-binding protein C with an early onset and a high penetrance in males
Méndez, I., Fernández, A. I., Espinosa, M. Á., Cuenca, S., Lorca, R., Rodríguez, J. F., Tamargo, M., Garcia-Montero, M., Gómez, C., Vilches, S., et al. (2021) · Open Heart · doi:10.1136/openhrt-2021-001789 · Cited by 17
Cardiopulmonary Fitness and Personalized Exercise Prescription in Patients With Hypertrophic Cardiomyopathy
Cavigli, L., Ragazzoni, G. L., Vannuccini, F., Targetti, M., Mandoli, G. E., Senesi, G., Pastore, M. C., Focardi, M., Cameli, M., Valente, S., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.036593 · Cited by 17
Advances in Multimodality Cardiovascular Imaging in the Diagnosis of Heart Failure With Preserved Ejection Fraction
Torto, A. D., Guaricci, A. I., Pomarico, F., Guglielmo, M., Fusini, L., Monitillo, F., Santoro, D., Vannini, M., Rossi, A., Muscogiuri, G., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.758975 · Cited by 16
The Additional Value of T1 Mapping in Cardiac Disease: State of the Art
Ascione, R., Giorgi, M. D., Dell’Aversana, S., Costanzo, G., Nappi, C., Imbriaco, M., & Ponsiglione, A. (2023) · Current Cardiovascular Imaging Reports · doi:10.1007/s12410-023-09588-y · Cited by 16
Low T3 syndrome predicts more adverse events in patients with hypertrophic cardiomyopathy
He, C., Zhu, C., Fan, H., Qian, Y., Zhai, C., & Hu, H. (2023) · Clinical Cardiology · doi:10.1002/clc.24156 · Cited by 15
Healthcare resource utilization and cost of obstructive hypertrophic cardiomyopathy in a US population
Butzner, M., Maron, M. S., Sarocco, P., Teng, C., Stanek, E. J., Tan, H., & Robertson, L. (2022) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2022.100089 · Cited by 15
Self-citation
Future Role of New Negative Inotropic Agents in the Era of Established Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy
Maron, B. J., Maron, M. S., Sherrid, M. V., & Rowin, E. J. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.024566 · Cited by 15
Self-citation
Diagnosis and Clinical Implication of Left Ventricular Aneurysm in Hypertrophic Cardiomyopathy
Perillo, E. F., Canciello, G., Borrelli, F., Todde, G., Imbriaco, M., Ordine, L., Napoli, S., Lombardi, R., Esposito, G., & Losi, M. A. (2023) · Diagnostics · doi:10.3390/diagnostics13111848 · Cited by 14
2023 Expert Consensus of the Taiwan Society of Cardiology on the Diagnosis and Treatment of Cardiac Amyloidosis.
Wang, C., Chang, W., Lin, Y., Tzeng, B., Chao, T., Hung, C., Wu, Y., Tsai, C., Lin, W.-W., Chang, K., et al. (2023) · PubMed Central · doi:10.6515/acs.202307_39(4).20230610a · Cited by 14
Midterm Outcomes of Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Cardiomyopathy: A Single‐Center, Observational Study
Xie, X., Chen, S., Cui, Y., Zhou, Z., Lü, J., Du, Z. J., Ding, J., Xing, K., Zhang, Y., Zhou, Y., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.034080 · Cited by 14
Review of Contemporary Invasive Treatment Approaches and Critical Appraisal of Guidelines on Hypertrophic Obstructive Cardiomyopathy: State-of-the-Art Review
Lebowitz, S., Kowalewski, M., Raffa, G. M., Chu, D., Greco, M., Gandolfo, C. M., Mignosa, C., Lorusso, R., Suwalski, P., & Pilato, M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11123405 · Cited by 14
Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy and Cardiac Amyloidosis: From Clinical Management to Catheter Ablation Indication
Mistrulli, R., Ferrera, A., Muthukkattil, M. L., Battistoni, A., Gallo, G., Barbato, E., Spera, F. R., & Magrì, D. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13020501 · Cited by 14
Age-Related Survival After Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy
Batzner, A., Aicha, D., Pfeiffer, B., Neugebauer, A., & Seggewiß, H. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13750 · Cited by 14
Cardiac device implantation and device usage in Fabry and hypertrophic cardiomyopathy
Vijapurapu, R., Bradlow, W. M., Leyva, F., Moon, J., Zegard, A., Lewis, N. T., Kotecha, D., Jovanović, A., Hughes, D. A., Woolfson, P. I., et al. (2022) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-021-02133-4 · Cited by 14
Clonal Haematopoiesis is Associated with Major Adverse Cardiovascular Events in Patients with Hypertrophic Cardiomyopathy
Scolari, F. L., Brahmbhatt, D. H., Abelson, S., Lee, D. Z. J., Kim, R. H., Pedarzadeh, A., Sakhnini, A., Adler, A., Chan, R. H. M., Dick, J. E., et al. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3408 · Cited by 13
Cardiopulmonary Exercise Testing in Pediatric Patients With Hypertrophic Cardiomyopathy
Edelson, J. B., Stanley, H. M., Min, J., Burstein, D. S., Lane-Fall, M. B., O’Malley, S., Shah, M. J., McBride, M. G., Stephens, P., Griffis, H. M., et al. (2022) · JACC Advances · doi:10.1016/j.jacadv.2022.100107 · Cited by 13
Papillary-Muscle-Derived Radiomic Features for Hypertrophic Cardiomyopathy versus Hypertensive Heart Disease Classification
Liu, Q., Lu, Q., Chai, Y., Tao, Z., Wu, Q.-Z., Jiang, M., & Pu, J. (2023) · Diagnostics · doi:10.3390/diagnostics13091544 · Cited by 13
The Importance of Left Ventricular Outflow Tract and Mid-Ventricular Gradients in Stress Echocardiography: A Narrative Review
Cotrim, C., Pálinkás, E. D., & Cotrim, N. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12165292 · Cited by 13
Natural History and Clinical Outcomes of Patients with Hypertrophic Cardiomyopathy from Thin Filament Mutations
Saul, T., Bui, Q. M., Argirò, A., Keyt, L. K., Olivotto, I., & ADLER, E. D. (2024) · ESC Heart Failure · doi:10.1002/ehf2.14848 · Cited by 12
Sudden Cardiac Death in Athletes.
Tsang, D. C., & Link, M. S. (2021) · PubMed Central · doi:10.14503/thij-20-7513 · Cited by 2
Self-citation
Ablação Septal com Cateteres e Radiofrequência Guiada pela Ecocardiografia para Tratamento de Pacientes com Cardiomiopatia Hipertrófica Obstrutiva: Experiência Inicial
Valdigem, B. P., Correia, E. B., Moreira, D. A. R., Bihan, D. C. D. S. L., Pinto, I. M. F., Abizaid, A., Andalaft, R. B., Paladino, A. T., da Silva, H. A. G. P., & Viesi, J. H. Z. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20200732 · Cited by 12
The Role of Multimodality Imaging in Pediatric Cardiomyopathies
Moscatelli, S., Leo, I., Bianco, F., Borrelli, N., Beltrami, M., Garofalo, M., Milano, E., Bisaccia, G., Iellamo, F., Bassareo, P., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144866 · Cited by 12
Premature Ventricular Contraction-Induced Cardiomyopathy: Contemporary Evidence from Risk Stratification, Pathophysiology, and Management
Attachaipanich, T., Thiravetyan, B., Tribuddharat, N., Jaroonpipatkul, S., & Navaravong, L. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13092635 · Cited by 11
Arrhythmia Monitoring for Risk Stratification in Hypertrophic Cardiomyopathy
Du, D., Li, C. O. Y., Ong, K., Parsa, A., Weissler‐Snir, A., Geske, J. B., & Laksman, Z. (2022) · CJC Open · doi:10.1016/j.cjco.2022.01.001 · Cited by 11
Usefulness of Longitudinal Strain Adjusted to Regional Thickness in Hypertrophic Cardiomyopathy
Urtado, S., Hergault, H., Binsse, S., Aïdan, V., Ouadahi, M., Szymanski, C., Mallet, S., Hauguel‐Moreau, M., Carlier, R., Dubourg, O., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11082089 · Cited by 11
Comparison of left ventricular global and segmental strain parameters by cardiovascular magnetic resonance tissue tracking in light-chain cardiac amyloidosis and hypertrophic cardiomyopathy
Wang, F., Xu, X., Wang, Q., Yu, D., Lv, L., & Wang, Q. (2022) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-22-329 · Cited by 11
Inequities in Treatments and Outcomes Among Patients Hospitalized With Hypertrophic Cardiomyopathy in the United States
Johnson, D. Y., Waken, R. J., Fox, D. K., Hammond, G., Maddox, K. E. J., & Cresci, S. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.029930 · Cited by 11
Safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of aficamten in healthy Chinese participants: a randomized, double-blind, placebo-controlled, phase 1 study
Zhao, X., Liu, H., Tian, W., Fang, L., Yu, M., Wu, X., Liu, A., Wan, R., Li, L., Luo, J., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1227470 · Cited by 11
Evaluation of the relationship between left atrial strain and exercise tolerance in patients with hypertrophic cardiomyopathy by treadmill stress echocardiography
Su, Y., Li, C., & Yin, L. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1168514 · Cited by 10
Myocardial Characterization on CT: Late Iodine Enhancement and Extracellular Volume
Bartoli, A., Gnasso, C., Palmisano, A., Bettinelli, A., Vignale, D., & Esposito, A. (2025) · Echocardiography · doi:10.1111/echo.70108 · Cited by 10
Arrhythmias and Sudden Death: What is New in Hypertrophic Cardiomyopathy?
Rajan, D., Zörner, C. R., Hansen, M. L., & Tfelt‐Hansen, J. (2025) · Cardiac failure review · doi:10.15420/cfr.2024.38 · Cited by 10
Selection of patients eligible for implantable cardioverter defibrillator: beyond left ventricular ejection fraction
Rizzello, V. (2022) · European Heart Journal Supplements · doi:10.1093/eurheartjsupp/suac087 · Cited by 10
Long-term outcomes of surgery for obstructive hypertrophic cardiomyopathy in a pediatric cohort
Nguyen, S. N., Chung, M., Vinogradsky, A., Richmond, M. E., Zuckerman, W. A., Goldstone, A. B., & BACHA, E. A. (2023) · JTCVS Open · doi:10.1016/j.xjon.2023.09.032 · Cited by 10

Authors: Writing Committee Members, Ommen, S. R., Mital, S., Burke, M. A., Day, S. M., Deswal, A., Elliott, P., Evanovich, L. L., Hung, J., Joglar, J. A., Kantor, P., Kimmelstiel, C., Kittleson, M., Link, M. S., Maron, M. S., Martinez, M. W., Miyake, C. Y., Schaff, H. V., Semsarian, C., & Sorajja, P.
Affiliations: ACC/AHA Representative.
American Hospital Association (US)
ASE Representative.
HRS Representative.
SCMR Representative.
AATS Representative.
SCAI Representative.
ORCID: Ommen, Steve R.
Mital, Seema
Burke, Michael A.
Day, Sharlene M.
Deswal, Anita
Hung, Judy
Joglar, José A.
Kantor, Paul
Kimmelstiel, Carey
Kittleson, Michelle
Link, Mark S.
Maron, Martin S.
Martinez, Matthew W.
Miyake, Christina Y.
Schaff, Hartzell V.
Semsarian, Christopher
Sorajja, Paul
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2020-12-22
Volume: 142
Issue: 25
Pages: e533-e557
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/cir.0000000000000938
OpenAlex: W3113392623
Cited by: 336
References: 317
Citations by year: 2026: 38 · 2025: 46 · 2024: 64 · 2023: 77 · 2022: 70 · 2021: 39 · 2020: 1
FWCI: 30.28
Type: journal article
Language: en
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
Keywords: hypertrophic cardiomyopathy, diagnosis, treatment, guideline-directed medical therapy, risk stratification, genetic screening, family screening, lifestyle modification, surgical treatment, interventional catheterization, medication, pediatric patients, adult patients
MeSH terms: Algorithms, American Heart Association, Cardiology, Cardiomyopathy, Hypertrophic, Decision Support Techniques, Humans, Predictive Value of Tests, United States, Treatment Outcome, Evidence-Based Medicine, Consensus, Cardiac Imaging Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks